Lion Biotechnologies CSO Laszlo Radvanyi Co-authors Study in Clinical Cancer Research
12 janv. 2015 08h00 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, Jan. 12, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes (TIL),...
Lion Biotechnologies to Present at Biotech Showcase
06 janv. 2015 08h00 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, Jan. 6, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (LBIO) announced that president and CEO Elma Hawkins, PhD, will present at the Biotech Showcase on Monday, January 12, 2015....
Lion Biotechnologies Submits Investigational New Drug Application to Conduct Phase 2 Study in Metastatic Melanoma
05 janv. 2015 08h00 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, Jan. 5, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc., a biotechnology company that is developing novel cancer immunotherapies, today announced that it has filed an investigational...
Lion Biotechnologies Announces Closing of Underwritten Common Stock Offering
22 déc. 2014 16h01 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, Dec. 22, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating...
Lion Biotechnologies Announces Pricing of Underwritten Common Stock Offering
17 déc. 2014 09h00 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, Dec. 17, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...
Lion Biotechnologies Names Elma Hawkins President, Chief Executive Officer and Director
15 déc. 2014 08h00 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, Dec. 15, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc., a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes (TIL), today...
Lion Biotechnologies Announces Positive New Data From Lead TIL Melanoma Program at ASH
08 déc. 2014 08h00 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, Dec. 8, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TILs)...
Lion Biotechnologies to Present at the Piper Jaffray 26th Annual Healthcare Conference
01 déc. 2014 08h00 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (LBIO), a biotechnology company focused on the development and commercialization of novel cancer immunotherapies based on...
Lion Biotechnologies Announces Clinical Data Update at American Society of Hematology Annual Meeting
21 nov. 2014 08h00 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, Nov. 21, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TILs)...
Lion Biotechnologies Announces Management Change
12 nov. 2014 16h05 HE
|
Lion Biotechnologies, Inc.
LOS ANGELES, Nov. 12, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCBB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...